-
Something wrong with this record ?
The emergence of Clostridium difficile ribotypes 027 and 176 with a predominance of the Clostridium difficile ribotype 001 recognized in Slovakia following the European standardized Clostridium difficile infection surveillance of 2016
E. Novakova, M. Stefkovicova, MG. Kopilec, M. Novak, N. Kotlebova, E. Kuijper, M. Krutova,
Language English Country Canada
Document type Journal Article
NLK
Directory of Open Access Journals
from 1996
Free Medical Journals
from 1996 to 1 year ago
Open Access Digital Library
from 1996-07-01
Open Access Digital Library
from 1996-01-01
ROAD: Directory of Open Access Scholarly Resources
- MeSH
- Anti-Bacterial Agents pharmacology MeSH
- Clostridioides difficile classification drug effects genetics isolation & purification MeSH
- Incidence MeSH
- Clostridium Infections epidemiology microbiology MeSH
- Infant MeSH
- Humans MeSH
- Adolescent MeSH
- Moxifloxacin pharmacology MeSH
- Ribotyping MeSH
- Aged MeSH
- Check Tag
- Infant MeSH
- Humans MeSH
- Adolescent MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Geographicals
- Slovakia MeSH
AIM: To obtain standardized epidemiological data for Clostridium difficile infection (CDI) in Slovakia. METHODS: Between October and December 2016, 36 hospitals in Slovakia used the European Centre for Disease Prevention and Control (ECDC) Clostridium difficile infection (CDI) surveillance protocol. RESULTS: The overall mean CDI incidence density was 2.8 (95% confidence interval 1.9-3.9) cases per 10 000 patient-days. Of 332 CDI cases, 273 (84.9%) were healthcare-associated, 45 (15.1%) were community-associated, and 14 (4.2%) were cases of recurrent CDI. A complicated course of CDI was reported in 14.8% of cases (n=51). CDI outcome data were available for 95.5% of cases (n=317). Of the 35 patients (11.1%) who died, 34 did so within 30 days after their CDI diagnosis. Of the 78 isolates obtained from 12 hospitals, 46 belonged to PCR ribotype 001 (59.0%; 11 hospitals) and 23 belonged to ribotype 176 (29.5%; six hospitals). A total of 73 isolates (93.6%) showed reduced susceptibility to moxifloxacin (ribotypes 001 and 176; p< 0.01). A reduced susceptibility to metronidazole was observed in 13 isolates that subsequently proved to be metronidazole-susceptible when, after thawing, they were retested using the agar dilution method. No reduced susceptibility to vancomycin was found. CONCLUSIONS: These results show the emergence of C. difficile ribotypes 027 and 176 with a predominance of ribotype 001 in Slovakia in 2016. Given that an almost homogeneous reduced susceptibility to moxifloxacin was detected in C. difficile isolates, this stresses the importance of reducing fluoroquinolone prescriptions in Slovak healthcare settings.
Department of Epidemiology Regional Public Health Authority Trenčín Slovakia
Department of Medical Microbiology Leiden University Medical Centre Leiden The Netherlands
Department of Public Health Comenius University Jessenius Faculty of Medicine in Martin Slovakia
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20005709
- 003
- CZ-PrNML
- 005
- 20200527094949.0
- 007
- ta
- 008
- 200511s2020 xxc f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ijid.2019.10.038 $2 doi
- 035 __
- $a (PubMed)31707136
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxc
- 100 1_
- $a Novakova, Elena $u Department of Microbiology and Immunology, Comenius University, Jessenius Faculty of Medicine in Martin, Slovakia.
- 245 14
- $a The emergence of Clostridium difficile ribotypes 027 and 176 with a predominance of the Clostridium difficile ribotype 001 recognized in Slovakia following the European standardized Clostridium difficile infection surveillance of 2016 / $c E. Novakova, M. Stefkovicova, MG. Kopilec, M. Novak, N. Kotlebova, E. Kuijper, M. Krutova,
- 520 9_
- $a AIM: To obtain standardized epidemiological data for Clostridium difficile infection (CDI) in Slovakia. METHODS: Between October and December 2016, 36 hospitals in Slovakia used the European Centre for Disease Prevention and Control (ECDC) Clostridium difficile infection (CDI) surveillance protocol. RESULTS: The overall mean CDI incidence density was 2.8 (95% confidence interval 1.9-3.9) cases per 10 000 patient-days. Of 332 CDI cases, 273 (84.9%) were healthcare-associated, 45 (15.1%) were community-associated, and 14 (4.2%) were cases of recurrent CDI. A complicated course of CDI was reported in 14.8% of cases (n=51). CDI outcome data were available for 95.5% of cases (n=317). Of the 35 patients (11.1%) who died, 34 did so within 30 days after their CDI diagnosis. Of the 78 isolates obtained from 12 hospitals, 46 belonged to PCR ribotype 001 (59.0%; 11 hospitals) and 23 belonged to ribotype 176 (29.5%; six hospitals). A total of 73 isolates (93.6%) showed reduced susceptibility to moxifloxacin (ribotypes 001 and 176; p< 0.01). A reduced susceptibility to metronidazole was observed in 13 isolates that subsequently proved to be metronidazole-susceptible when, after thawing, they were retested using the agar dilution method. No reduced susceptibility to vancomycin was found. CONCLUSIONS: These results show the emergence of C. difficile ribotypes 027 and 176 with a predominance of ribotype 001 in Slovakia in 2016. Given that an almost homogeneous reduced susceptibility to moxifloxacin was detected in C. difficile isolates, this stresses the importance of reducing fluoroquinolone prescriptions in Slovak healthcare settings.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a antibakteriální látky $x farmakologie $7 D000900
- 650 _2
- $a klostridiové infekce $x epidemiologie $x mikrobiologie $7 D003015
- 650 _2
- $a Clostridioides difficile $x klasifikace $x účinky léků $x genetika $x izolace a purifikace $7 D016360
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a incidence $7 D015994
- 650 _2
- $a kojenec $7 D007223
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a moxifloxacin $x farmakologie $7 D000077266
- 650 _2
- $a ribotypizace $7 D021521
- 651 _2
- $a Slovenská republika $x epidemiologie $7 D018154
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Stefkovicova, Maria $u Department of Epidemiology, Regional Public Health Authority, Trenčín, Slovakia; Department of Laboratory Medicine and Public Health, Faculty of Health Care, Alexander Dubcek University, Trenčín, Slovakia.
- 700 1_
- $a Kopilec, Maria Garabasova $u Department of Epidemiology, Regional Public Health Authority, Trenčín, Slovakia.
- 700 1_
- $a Novak, Martin $u Department of Public Health, Comenius University, Jessenius Faculty of Medicine in Martin, Slovakia.
- 700 1_
- $a Kotlebova, Nina $u Department of Microbiology and Immunology, Comenius University, Jessenius Faculty of Medicine in Martin, Slovakia.
- 700 1_
- $a Kuijper, Ed $u Department of Medical Microbiology, Leiden University Medical Centre, Leiden, The Netherlands.
- 700 1_
- $a Krutova, Marcela $u Department of Medical Microbiology, Charles University in Prague, 2nd Faculty of Medicine and Motol University Hospital, Prague, Czech Republic. Electronic address: marcela.krutova@lfmotol.cuni.cz.
- 773 0_
- $w MED00005677 $t International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases $x 1878-3511 $g Roč. 90, č. - (2020), s. 111-115
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31707136 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200511 $b ABA008
- 991 __
- $a 20200527094946 $b ABA008
- 999 __
- $a ok $b bmc $g 1524567 $s 1095765
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 90 $c - $d 111-115 $e 20191109 $i 1878-3511 $m International journal of infectious diseases $n Int J Infect Dis $x MED00005677
- LZP __
- $a Pubmed-20200511
